Recent Updates
Recently added Catalysts
HCSG Positive Sentiment Score: 65/100

HEALTHCARE SERVICES GROUP, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands)

Key Takeaway: Healthcare Services Group, Inc. reported a revenue of $424.0 million and a net income of $16.2 million for Q4 2022. The company suspended its quarterly cash dividend to shift focus on a stock repurchase strategy, planning to buy back up to 7.5 million shares. CEO Ted Wahl expressed optimism about the company’s resilience and growth outlook, despite facing ongoing challenges related to the workforce and inflation. The company aims to enhance financial flexibility and continue investing in future opportunities.

Market Sentiment Analysis

POSITIVE FACTORS

  • Achieved a revenue increase to $424.0 million in Q4 2022.
  • Suspended quarterly cash dividend to prioritize share repurchase, enhancing financial flexibility.
  • Reported strong net income of $16.2 million, signifying operational growth.
  • CEO expresses confidence in the growth outlook and improving industry conditions.

CONCERNS & RISKS

  • Suspension of the quarterly cash dividend may concern shareholders about immediate returns.
  • Direct costs were high at $366.8 million, indicating pressure on profit margins.
  • Ongoing challenges related to workforce availability and inflation may impact future profitability.
  • Potential risks include significant customer dependency and evolving industry regulations.

Full Press Release Details

Healthcare Services Group, Inc.
Reports Q4 2022 Results
Achieves Direct Cost Target, Rebalances Capital Allocation Strategy
BENSALEM, PA--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ HCSG) (the "Company") reported for the three months ended December 31, 2022 revenue of $424.0 million, net income of $16.2 million, or $0.22 per basic and diluted common share, and cash flow from operations of $22.9 million. The Company also announced that, as part of a comprehensive rebalancing of its capital allocation strategy, its Board of Directors has suspended the quarterly cash dividend on its common stock and authorized the repurchase of up to 7.5 million shares of its common stock.
Revenue for the quarter was reported at $424.0 million, with housekeeping laundry and dining nutrition segment revenues of $198.0 million and $226.0 million, respectively.
Housekeeping laundry and dining nutrition segment margins were 8.7% and 4.3%, respectively.
Direct cost of services was reported at $366.8 million, or 86.5%. Direct cost included a $9.8 million benefit related to favorable workers' compensation loss development trends offset, in part, by an $8.6 million increase in AR reserves.
Selling, general and administrative ("SG A") was reported at $39.5 million after adjusting for the $2.1 million increase in deferred compensation, actual SG A was $37.4 million, or 8.8%.
The effective tax rate was 19.4% for the fourth quarter and 23.2% for full year 2022. The Company expects a 2023 tax rate of 24% to 26%.
Cash flow from operations for the quarter was $22.9 million and was impacted by a $3.1 million decrease in accrued payroll, including the impact of the second half, or $24.4 million, of the deferred FICA payment. DSO for the quarter was 72 days.
Ted Wahl, Chief Executive Officer, stated, "I'm pleased with our fourth quarter results, which underscore the resilience of our business model and continued passion and perseverance of our people in a challenging operating environment. We achieved our 2022 goal of exiting the year with cost of services in line with our historical target of 86%, met our Q4 goal of collecting what we bill,' and have a growing pipeline of future client-partners as we head into 2023."
Mr. Wahl continued, "While the industry continues to face headwinds related to workforce availability, inflation and supply chain constraints, we are encouraged by the gradual but steadily improving facility census and labor market trends. We will continue to closely monitor industry dynamics, and we remain confident that the growth outlook for the Company remains strong given our market leadership, efficient operating model and the attractive demographics."
The Company, as part of its disciplined and balanced approach to managing capital, is rebalancing its capital allocation strategy to enhance financial flexibility, invest in organic and inorganic opportunities and accelerate value creation. As such, the Board of Directors has suspended the quarterly cash dividend on its common stock and authorized the repurchase of up to 7.5 million shares of its common stock.
Mr. Wahl stated, "The Board regularly reviews the Company's capital allocation strategy to ensure it supports our goal of creating value for shareholders by delivering on our near-term operational objectives and our growth outlook. As we look at the current opportunities, we believe that rebalancing our approach to allocating capital - especially given the prolonged industry recovery, ongoing macroeconomic challenges and our strong liquidity position - will result in more proactive, impactful and enduring value creation in the coming years."
Conference Call and Upcoming Events
The Company will host a conference call on Wednesday, February 15, 2023, at 8 30 a.m. Eastern Time to discuss its results for the three months ended December 31, 2022. The call may be accessed via phone at 1 (888) 330-3451, Conference ID 4431380. The call will be simultaneously webcast under the "Events Presentations" section of the Investor Relations page on the Company's website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes," "anticipates," "plans," "expects," "estimates," "will," "goal," and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care the impact of and future effects of the COVID-19 pandemic or other potential pandemics having a significant portion of our consolidated revenues contributed by one customer during the year ended December 31, 2022 credit and collection risks associated with the healthcare industry our claims experience related to workers' compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19) the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases the Company's expectations with respect to selling, general, and administrative expense and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2021 under "Government Regulation of Clients," "Service Agreements and Collections," and "Competition" and under Item 1A. "Risk Factors" in such Form 10-K.
These factors, in addition to delays in payments from customers and or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.
In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.
Company Contacts
Theodore Wahl Matthew J. McKee
President and Chief Executive Officer Chief Communications Officer
215-639-4274
investor-relations hcsgcorp.com
HEALTHCARE SERVICES GROUP, INC.
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
For the Three Months Ended For the Year Ended
December 31, December 31,
2022 2021 2022 2021
Revenues $ 424,020 $ 420,447 $ 1,690,176 $ 1,641,959
Operating costs and expenses
Cost of services provided 366,810 377,230 1,496,336 1,415,082
Selling, general and administrative 39,524 44,290 140,344 173,108
Income from operations 17,686 (1,073) 53,496 53,769
Other income, net
Investment and other income (expense), net 2,372 2,760 (8,414) 8,054
Income before income taxes 20,058 1,687 45,082 61,823
Income tax expense (benefit) 3,899 (418) 10,452 15,960
Net income $ 16,159 $ 2,105 $ 34,630 $ 45,863
Basic earnings per common share $ 0.22 $ 0.03 $ 0.47 $ 0.61
Diluted earnings per common share $ 0.22 $ 0.03 $ 0.47 $ 0.61
Basic weighted average number of common shares outstanding 74,342 74,318 74,336 74,816
Diluted weighted average number of common shares outstanding 74,367 74,342 74,351 74,962
HEALTHCARE SERVICES GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
December 31, 2022 December 31, 2021
Cash and cash equivalents $ 26,279 $ 70,794
Marketable securities, at fair value 95,200 114,396
Accounts and notes receivable, net 336,777 293,388
Other current assets 50,376 67,804
Total current assets 508,632 546,382
Property and equipment, net 22,975 28,102
Notes receivable - long-term 32,609 29,259
Goodwill 75,529 74,755
Other intangible assets, net 15,946 20,805
Deferred compensation funding 33,493 46,691
Other assets 29,150 31,535
Total Assets $ 718,334 $ 777,529
Accrued insurance claims - current $ 23,166 $ 24,310
Other current liabilities 155,453 166,815
Total current liabilities 178,619 191,125
Accrued insurance claims - long-term 65,541 65,084
Deferred compensation liability 33,764 46,888
Other non-current liabilities 14,238 21,755
Stockholders' equity 426,172 452,677
Total Liabilities and Stockholders' Equity $ 718,334 $ 777,529

Frequently Asked Questions

What were the Q4 2022 revenue figures for HCSG?

HCSG reported Q4 2022 revenue of $424.0 million.

What is the effective tax rate for HCSG in Q4 2022?

The effective tax rate for HCSG was 19.4% in Q4 2022.

How much cash flow from operations did HCSG achieve in Q4 2022?

HCSG achieved cash flow from operations of $22.9 million in Q4 2022.

What changes did HCSG make to its capital allocation strategy?

HCSG suspended its quarterly cash dividend and authorized a share repurchase of up to 7.5 million shares.

When is HCSG's next conference call scheduled?

HCSG will host its next conference call on February 15, 2023.

Last updated: Feb 15, 2023